Form 15-15D - Suspension of duty to report [Section 13 and 15(d)]:
SEC Accession No. 0000950144-03-008115
Filing Date
2003-06-27
Accepted
2003-06-27 14:31:04
Documents
1
Effectiveness Date
2003-06-27

Document Format Files

Seq Description Document Type Size
1 NABI BIOPHARMACEUTICALS g83597e15v15d.htm 15-15D 8152
  Complete submission text file 0000950144-03-008115.txt   9910
Mailing Address 5800 PARK OF COMMERCE BLVD NW STE 322 BOCA RATON FL 33487
Business Address 5800 PARK OF COMMERCE BLVD N W STE 322 BOCA RATON FL 33487 5619895800
NABI BIOPHARMACEUTICALS (Filer) CIK: 0000072444 (see all company filings)

EIN.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1225
Type: 15-15D | Act: 34 | File No.: 002-32419 | Film No.: 03760704
SIC: 2836 Biological Products, (No Diagnostic Substances)